krielisa_ Profile Banner
Lisa Kriegl Profile
Lisa Kriegl

@krielisa_

Followers
95
Following
538
Media
1
Statuses
87

MD in infectious disease at Medical University of Graz, Austria, with a special heart for bacteria and fungi. 🧫🔬🌍

Graz, Österreich
Joined March 2022
Don't wanna be here? Send us removal request.
@OFIDJournal
Open Forum Infectious Diseases
8 days
Triazoles versus Echinocandins for the first-line treatment of invasive pulmonary aspergillosis ? A propensity score weighted multicenter study ✅ Just Accepted 🔗 https://t.co/nMsgHgFFKD
1
7
20
@TheLancet
The Lancet
1 month
Community-acquired pneumonia is the leading infectious cause of morbidity & mortality globally. Yet there are several challenges associated with diagnosis, treatment, & long-term management of Community-acquired pneumonia. Find out more in a new Seminar: https://t.co/4NsK4lDwOL
0
58
140
@TakaMatsuo_ID
Takahiro Matsuo (Taka), MD
1 month
@RizwanSohailMD
M. Rizwan Sohail, MD
6 years
Respiratory infections in immunocompromised patients. Chalk talk to fellows during morning rounds. @MayoClinicINFD
0
13
68
@1min_IDconsult
1-min ID consult
2 months
【Splenic Abscess】 In addition to Staph/Strep, it is also important to consider other microorganisms! Level: Intermediate to advanced #IDMedEd #IDFellow #IMResident
0
34
147
@CIDJournal
Clinical Infectious Diseases
2 months
Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study ✅ Just Accepted https://t.co/RVMRonexgj
Tweet card summary image
academic.oup.com
In this study of 172 ICU patients with influenza-related ARDS, empirical antifungal treatment was associated with reduced pulmonary aspergillosis incidence
1
17
37
@ABsteward
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟
3 months
🆕🔥 Review article @TheLancetInfDis Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults #IDXposts https://t.co/GHXWzMVSdB
1
92
209
@ESCMID
ESCMID
5 months
Happy faces at the 23rd edition of the ESCMID Summer School that has been taking place this week in Dublin, Ireland! Today the students are off on immersive field visits to four leading healthcare institutions in Dublin. A big thank you to all our partners! #ID #Clinmicro
0
3
13
@NatureRevMicro
Nature Reviews Microbiology
8 months
New online! Commensalism and pathogenesis of Candida albicans at the mucosal interface https://t.co/UZauiNNRHR
2
45
143
@ABsteward
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟
8 months
Just published 🔥 The WHO published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for innovative research and development (R&D) to close these gaps. #idxposts https://t.co/sbDlnHvBA4
0
51
130
@martinhoenigl
Martin Hoenigl🇺🇦🇦🇹
8 months
Projekt „GALActIC“ startet: Biomarker für Pilzinfektionen erforscht https://t.co/LGpIguaJgx
1
3
9
@Galactic_europe
Galactic
9 months
New Medical Study Starting Soon 🔬 The logo was designed in collaboration with Galactic Partners, with professional support from Esra Sedik. Follow us for more! @martinhoenigl @SarahSedik @Stella_A_I @carvalho_ago @s_feys @eurconfmedmycol @MSG_ERC @UZLeuven @MedUniGraz
0
4
6
@martinhoenigl
Martin Hoenigl🇺🇦🇦🇹
9 months
2025 Update on new antifungals now available on the ECMM youtube channel. Make sure you subscribe to receive automatic updates. https://t.co/d1hRaMiVc6
@martinhoenigl
Martin Hoenigl🇺🇦🇦🇹
3 years
Please visit our CLINICAL MYCOLOGY @YouTube Channel posting videos of some of the latest and 🔥🔥 scientific webinars educational presentations in the field. Never miss an update by Subscribing here👇 https://t.co/FnKV5WZa6E
1
15
41
@jprattes
Jürgen Prattes
9 months
Fully packed 2nd symposium of the austrian society of medical mycology (ÖGMM) - thanks to all speakers and participants for the interactive sessions
0
5
14
@ABsteward
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟
11 months
🆕💫 Retrospective multicentre study Pulmonary Co-Infection of Pneumocystis jirovecii and Aspergillus species #IDXposts
Tweet card summary image
academic.oup.com
Abstract. In this multicenter study of 387 patients who were immunocompromised, 4.5% with invasive pulmonary aspergillosis also had Pneumocystis jirovecii
0
21
50